The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Forecasted Market Size Figures For The Single-Cell Genome Sequencing Market In 2026 And 2030?
The single-cell genome sequencing market has experienced rapid expansion recently. It is projected to increase from $2.83 billion in 2025 to $3.26 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.2%. This historical growth can be attributed to factors such as early acceptance in research, restricted sequencing resolution, the significant expense of single-cell analysis, rising need for personalized medicine research, and an increase in genomic collaborations.
The single-cell genome sequencing market size is projected to experience significant expansion in the coming years. This market is anticipated to reach $5.84 billion by 2030, growing at a compound annual growth rate (CAGR) of 15.7%. The expected growth over the forecast period is primarily driven by the advancement of high-throughput single-cell platforms, increased adoption in clinical diagnostics, the integration of AI and bioinformatics, expanded use in multi-omics studies, and a rise in drug discovery applications. Prominent trends for the forecast period include a surging application in cancer research, deeper integration with multi-omics studies, broader adoption in drug discovery, the emergence of automated sequencing platforms, and an overall increase in clinical diagnostics applications.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp
What Influential Factors Are Boosting The Single-Cell Genome Sequencing Market Demand?
The rising incidence of cancer is anticipated to drive the expansion of the single-cell genome sequencing market in the coming years. Cancer represents a diverse group of diseases characterized by abnormal cells growing and dividing uncontrollably, stemming from genetic modifications that regulate cell division and normal cellular function. As cancer is fundamentally a disease involving genetic alterations, single-cell genome sequencing offers a tool to identify these genetic changes within individual cancer cells. For example, in January 2023, the American Cancer Society, a US-based organization dedicated to combating cancer, reported approximately 1.9 million new cancer cases and 609,360 cancer deaths in the US during 2022. Moreover, by 2040, new cancer cases are projected to reach around 27.5 million, with cancer deaths estimated at 16.3 million. Consequently, the growing occurrence of cancer is expected to fuel the development of the single-cell genome sequencing market.
What Are The Major Segment Categories Within The Single-Cell Genome Sequencing Market?
The single-cell genome sequencing market covered in this report is segmented –
1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users
Subsegments:
1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems
2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents
What Trends Are Influencing The Future Of The Single-Cell Genome Sequencing Market?
Leading companies within the single-use bioprocessing market are prioritizing innovative products like single-use process container films to achieve a competitive advantage and improve their technological portfolios. The Ultimus single-use process container film, for example, is integrated into Mobius 3D process containers, providing a remarkable tenfold increase in abrasion resistance compared to alternative single-use bioprocessing films. As an illustration, in April 2023, Merck Group, a Germany-based science and technology company, introduced its Single-Use Process Container Film. This solution aims to provide exceptional durability and leak resistance for single-use assemblies utilized in bioprocessing liquid applications. The Ultimus film is characterized by a unique woven nylon structure, which delivers enhanced bag strength and improved durability and resilience, thereby mitigating issues such as abrasions, tears, and material fatigue. Additionally, Ultimus film features an animal-origin-free contact resin with minimal extractables, which supports robust cell growth performance.
Who Are The Firms Contributing To The Single-Cell Genome Sequencing Market Ecosystem?
Major companies operating in the single-cell genome sequencing market are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.
Access The Complete Single-Cell Genome Sequencing Market Report:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Which Region Holds The Largest Share In The Single-Cell Genome Sequencing Market?
North America was the largest region in the single-cell genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Single-Cell Genome Sequencing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12655&type=smp
Browse Through More Reports Similar to the Global Single-Cell Genome Sequencing Market 2026, By The Business Research Company
Single Cell Analysis Market 2026
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market
Whole Genome And Exome Sequencing Global Market Report 2026
Metagenomic Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model